Resorbable implants comprising poly(butylene succinate) and copolymers thereof have been developed. The implants implants are preferably sterilized, and contain less than 20 endotoxin units per device as determined by the limulus amebocyte lysate (LAL) assay, and are particularly suitable for use in procedures where prolonged strength retention is necessary, and can include one or more bioactive agents. The implants may be made from fibers and meshes of poly(butylene succinate) and copolymers thereof, or by 3d printing, and the fibers may be oriented. Coverings and receptacles made from forms of poly(butylene succinate) and copolymers thereof have also been developed for use with cardiac rhythm management devices and other implantable devices. These coverings and receptacles may be used to hold, or partially/fully cover, devices such as pacemakers and neurostimulators. The coverings and receptacles are made from meshes, webs, lattices, non-wovens, films, fibers, and foams, and contain antibiotics such as rifampin and minocycline.

Resorbable implants comprising poly(butylene succinate) and copolymers thereof have been developed. The implants implants are preferably sterilized, and contain less than 20 endotoxin units per device as determined by the limulus amebocyte lysate (LAL) assay, and are particularly suitable for use in procedures where prolonged strength retention is necessary, and can include one or more bioactive agents. The implants may be made from fibers and meshes of poly(butylene succinate) and copolymers thereof, or by 3d printing, and the fibers may be oriented. Coverings and receptacles made from forms of poly(butylene succinate) and copolymers thereof have also been developed for use with cardiac rhythm management devices and other implantable devices. These coverings and receptacles may be used to hold, or partially/fully cover, devices such as pacemakers and neurostimulators. The coverings and receptacles are made from meshes, webs, lattices, non-wovens, films, fibers, and foams, and contain antibiotics such as rifampin and minocycline.

Resorbable implants comprising poly(butylene succinate) and copolymers thereof have been developed. The implants implants are preferably sterilized, and contain less than 20 endotoxin units per device as determined by the limulus amebocyte lysate (LAL) assay, and are particularly suitable for use in procedures where prolonged strength retention is necessary, and can include one or more bioactive agents. The implants may be made from fibers and meshes of poly(butylene succinate) and copolymers thereof, or by 3d printing, and the fibers may be oriented. Coverings and receptacles made from forms of poly(butylene succinate) and copolymers thereof have also been developed for use with cardiac rhythm management devices and other implantable devices. These coverings and receptacles may be used to hold, or partially/fully cover, devices such as pacemakers and neurostimulators. The coverings and receptacles are made from meshes, webs, lattices, non-wovens, films, fibers, and foams, and contain antibiotics such as rifampin and minocycline.

Resorbable implants comprising poly(butylene succinate) and copolymers thereof have been developed. The implants implants are preferably sterilized, and contain less than 20 endotoxin units per device as determined by the limulus amebocyte lysate (LAL) assay, and are particularly suitable for use in procedures where prolonged strength retention is necessary, and can include one or more bioactive agents. The implants may be made from fibers and meshes of poly(butylene succinate) and copolymers thereof, or by 3d printing, and the fibers may be oriented. Coverings and receptacles made from forms of poly(butylene succinate) and copolymers thereof have also been developed for use with cardiac rhythm management devices and other implantable devices. These coverings and receptacles may be used to hold, or partially/fully cover, devices such as pacemakers and neurostimulators. The coverings and receptacles are made from meshes, webs, lattices, non-wovens, films, fibers, and foams, and contain antibiotics such as rifampin and minocycline.

A composite fiber antibacterial fabric includes an antibacterial fabric body including multiple composite lines and multiple elastic fiber lines interweaving longitudinally and latitudinally. Each of the composite lines includes multiple multi-filament polyester fiber yarns and at least one or more than one fiber copper alloy wire blending and intertwining with the multi-filament polyester fiber yarns. The at least one or more than one fiber copper alloy wire has a filament shape with a determined flexibility. The at least one or more than one fiber copper alloy wire is oxidized to steadily release copper ions which act in the multi-filament polyester fiber yarns, so that each of the composite lines has an antibacterial function.

A method of making a yarn is disclosed. A plurality of fibers is obtained by: preparing a slurry of polymer mixed with water insoluble nanoparticles of electrolytic copper, and extruding the slurry through a spinneret that includes a plurality of holes which impart a generally X-shaped cross-section to the plurality of fibers. The plurality of fibers are spun together to form the yarn.

A method of making a yarn is disclosed. A plurality of fibers is obtained by: preparing a slurry of polymer mixed with water insoluble nanoparticles of electrolytic copper, and extruding the slurry through a spinneret that includes a plurality of holes which impart a generally X-shaped cross-section to the plurality of fibers. The plurality of fibers are spun together to form the yarn.

A polymer composition having antimicrobial properties, the composition comprising from 50 wt % to 99.99 wt % of a polymer, from 10 wppm to 900 wppm of zinc, less than 1000 wppm of phosphorus, and less than 10 wppm coupling agent and/or surfactant, wherein zinc is dispersed within the polymer; and wherein fibers formed from the polymer composition demonstrate a Klebsiella pneumonia log reduction greater than 0.90, as determined via ISO20743:2013 and/or an Escherichia coli log reduction greater than 1.5, as determined via ASTM E3160 (2018).

There is provided an air treatment apparatus comprising a body, an air flow generator housed within the body that is arranged to generate an air flow, an evaporator assembly removably disposed within the body and that is arranged to introduce water vapour into the air flow, and a water supply system that is arranged to provide water to the evaporator assembly. The water supply system comprises a water tank assembly that is separable from the body, the water tank assembly comprising a water tank having a tank opening. The tank opening is configured to allow the evaporator assembly to fit through the tank opening and the evaporator assembly is configured to fit within an interior volume of the water tank.

An artificial turf constructed on a floor of a sports stadium and used as a substitute for natural turf, specifically, an antibacterial artificial turf pile yarn includes 80 to 90% by weight of polyolefin resin, 3 to 10% by weight of a silicon-based compound, and 3 to 10% by weight of an antibacterial powder, wherein the antibacterial powder is copper sulfide powder, and the antibacterial artificial turf pile yarn is coated to have a cooling function, and wherein a PCM (phase change material) powder is mixed with one or more powers of titanium, aluminum, and graphene powders as a cooling material powder and coated on an artificial turf pile yarn with viscosity to have a cooling effect together with an antibacterial effect for inhibiting bacterial growth.